Evaluation of a Nutraceutical Containing Monacolin 2.94 Mg on Lipid Profile in Hypercholesterolemic Patients in Primary Prevention

Giuseppe Derosa^{1, 2,} , Giovanni Gaudio³, Angela D’Angelo^{1, 2} and Pamela Maffioli¹

¹Department of Internal Medicine and Therapeutics, University of Pavia, PAVIA, Italy

²Laboratory of Molecular Medicine, University of Pavia, PAVIA, Italy

³Internal Medicine Division, Ospedale Angelo Bellini, Somma Lombardo, VARESE, Italy

Cite this paper:
Giuseppe Derosa, Giovanni Gaudio, Angela D’Angelo and Pamela Maffioli. Evaluation of a Nutraceutical Containing Monacolin 2.94 Mg on Lipid Profile in Hypercholesterolemic Patients in Primary Prevention. Journal of Food and Nutrition Research. 2023; 11(10):608-613. doi: 10.12691/jfnr-11-10-1

Abstract

The aim of this study was to evaluate the changes in lipid profile, both at fasting and after an oral fat load (OFL), after 3 months of assumption of a nutraceutical containing monacolin K 2.94 mg, and other components as Cynara scolymus, Oryza sativa L., Brassica campestris L., folic acid, coenzyme Q10, and resveratrol compared to placebo in hypercholesterolemic patients in primary prevention. One hundred Caucasian patients were randomized to the nutraceutical or placebo for 3 months, an oral fat load was performed at baseline and at the trial end. Nutraceutical reduced total cholesterol (TC), triglycerides (Tg), and low-density lipoprotein-cholesterol (LDL-C), both compared to baseline, and to placebo. High sensitivity C-reactive protein decreased in the nutraceutical group both compared to baseline and to placebo. During the OFL performed after 3 months, there were lower levels of TC, and LDL-C compared to the OFL performed at baseline. TC, and LDL-C values were lowers also compared to placebo group at every time of OFL. Tg value recorded during the OFL at the end of the study was lower at 6 hours compared to baseline OFL, and placebo. The nutraceutical could be effective in improving lipid profile both at fasting and in a post-prandial condition.

Keywords:
monascus purpureus brassica campestris l. cynara scolymus oryza sativa l. polygenic hypercholesterolemia lipid profile

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart. J. 2020; 41(1): 111-188.
[2]	Wildman REC, Bruno RS. Handbook of Nutraceuticals and Functional Foods. 2020. CRC Press. ISBN 9781498703727.
[3]	Derosa G, D'Angelo A, Romano D, Maffioli P. Effects of a combination of Berberis aristata, Silybum marianum and Monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial. Int. J. Mol. Sci. 2017; 18(2): 343.
[4]	Cicero AF, Derosa G, Parini A, Maffioli P, D’Addato S, Reggi A, Giovannini M, Borghi C. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects. Nutr. Res. 2013; 33(8): 622-628.
[5]	D’Addato S, Scandiani L, Mombelli G, Focanti F, Pelacchi F, Salvatori E, Di Loreto G, Comandini A, Maffioli P, Derosa G. Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study. Drug Des. Devel. Ther. 2017; 11, 1585-1592.
[6]	Derosa G, Gaudio G, D’Angelo A, Maffioli P. Botanicals and food supplement combination in patients with polygenic hypercholesterolemia: evaluation at fasting and after oral fat load test. J. Food Nutr. Res. 2020; 8(12): 700-706.
[7]	https://efsa.onlinelibrary.wiley.com.
[8]	Feng S, Dai Z, Liu AB, Huang J, Narsipur N, Guo G, Kong B, Reuhl K, Lu W, Luo Z, Yang CS. Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 2018; 1863(10): 1274-1284.
[9]	Bundy R, Walker AF, Middleton RW, Wallis C, Simpson HCR. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo-controlled trial. Phytomedicine 2008; 15(9): 668-675.
[10]	Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & amp; rehabilitation (EACPR). Eur. Heart J. 2016; 37: 2315-2381.
[11]	Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J.A.M.A. 2001; 285(19): 2486-2497.
[12]	World Health Organization, 1997. Obesity: Preventing and Managing the Global Epidemic. Report of WHO Consultation on Obesity. Geneva: WHO.
[13]	Winer BJ. 1971. Statistical Principles in Experimental Design. 2nd ed, McGraw-Hill, New York.
[14]	Best MM, Duncan CH, Van Loon EJ, Wathen JD. The effects of sitosterol on serum lipids. Am. J. Med. 1955; 19(1): 61-70.
[15]	Batista-Jorge GC, Barcala-Jorge AS, Silveira MF, Lelis DF, Andrade JMO, de Paula AMB, Guimarães ALS, Santos SHS. Oral resveratrol supplementation improves Metabolic syndrome features in obese patients submitted to a lifestyle-changing program. Life Sci. 2020; 256: 117962.
[16]	Derosa G, D'Angelo A, Maffioli P. Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study. Drug Des. Devel. Ther. 2019; 13: 3647-3655.
[17]	Derosa G, Ferrari I, D’Angelo A, Salvadeo SA, Fogari E, Gravina A, Mereu R, Palumbo I, Maffioli P, Randazzo S, Cicero AF. Oral fat load effects on inflammation and endothelial stress markers in healthy subjects. Heart Vessels 2009; 24(3): 204-210.